Cellares Raises $82M in Series B Funding
Cellares Raises $82M in Series B Funding Cellares Corporation, a South San Francisco, Calif.-based life sciences technology company that automates cell therapy manufacturing, secured $82m in Series B round, bringing total funding to date to $100m. The round was led by new investor Decheng Capital with participation from existing investor Eclipse Ventures and 8VC and new backer Skyviews Life Science. The company intends to use the funds to accelerate development of the Cell Shuttle. Led by Fabian Gerlinghaus, co-founder and CEO, Cellares is advancing the Cell Shuttle, which enables end-to-...